| COLARIS® is a genetic test that requires a blood sample to determine if a patient has an HNPCC gene mutation and, therefore, a diagnosis of HNPCC. Once a diagnosis is made, there are specific management strategies that can be employed for early detection, risk reduction and possible prevention. |
|
|
Benefits of
Genetic Testing
Not only does COLARIS® genetic testing enable the physician to take a
proactive management approach with clearly identified
at-risk patients, but it can also enable clinicians
to: |
|
|
Avoid unnecessary interventions in
family members who did not test positive for the gene
mutation |
|
Target screening and surveillance to
only those with the HNPCC gene mutation, thus, increasing
clinical efficiency while saving costs |
|
Counsel patients and family members
on the underlying cause of cancer |
|
Significantly improve patient outcomes and reduce medical costs via early diagnosis and treatment of cancer, if it should develop. |
|
|
|
|
| Prospective data has shown that colonoscopic surveillance can save lives among patients with HNPCC. Overall survival is dramatically improved in mutation-positive patients who received regular colonoscopic screening, with a decrease in overall mortality by about 65 percent.7 |
|
|
Myriad Genetic
Laboratories Advantages
Myriad Genetic Laboratories offers the
most accurate test available to detect HNPCC, including: |
|
|
Proprietary automated robotics
systems that help decrease the chance of human error in the
analysis and ensure specimen integrity |
|
The Myriad Reimbursement Assistance
Program (MRAP) that helps patients maximize their payment
options for genetic testing. |
|
|
|
|
| For more information on COLARIS®, a genetic test for HNPCC, call Myriad Genetic Laboratories at
1-800-469-7423. Order a testing
kit online. |
|
|
| » Family
Matters |
|
|

A genetic test for hereditary nonpolyposis
colorectal cancer (HNPCC)
|